1 序文
2 調査範囲と方法論
2.1 調査の目的
2.2 ステークホルダー
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場推定
2.4.1 ボトムアップ・アプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法
3 エグゼクティブ・サマリー
4 はじめに
4.1 概要
4.2 主要産業動向
5 エネルギーベース治療薬の世界市場
5.1 市場概要
5.2 市場パフォーマンス
5.3 COVID-19の影響
5.4 技術タイプ別市場構成
5.5 臨床応用別市場構成比
5.6 エンドユーザー別市場構成比
5.7 地域別市場構成比
5.8 市場予測
6 技術タイプ別市場構成比
6.1 レーザーベース
6.1.1 市場動向
6.1.2 市場予測
6.2 ライトベース
6.2.1 市場動向
6.2.2 市場予測
6.3 ラジオ波ベース
6.3.1 市場動向
6.3.2 市場予測
6.4 超音波ベース
6.4.1 市場動向
6.4.2 市場予測
6.5 サーマル
6.5.1 市場動向
6.5.2 市場予測
6.6 その他
6.6.1 市場動向
6.6.2 市場予測
7 臨床用途別市場内訳
7.1 エステティック
7.1.1 市場動向
7.1.2 市場予測
7.2 外科
7.2.1 市場動向
7.2.2 市場予測
7.3 眼科
7.3.1 市場動向
7.3.2 市場予測
8 エンドユーザー別市場
8.1 病院
8.1.1 市場動向
8.1.2 市場予測
8.2 診療所
8.2.1 市場動向
8.2.2 市場予測
8.3 その他
8.3.1 市場動向
8.3.2 市場予測
9 地域別市場内訳
9.1 北米
9.1.1 市場動向
9.1.2 市場予測
9.2 欧州
9.2.1 市場動向
9.2.2 市場予測
9.3 アジア太平洋
9.3.1 市場動向
9.3.2 市場予測
9.4 中東・アフリカ
9.4.1 市場動向
9.4.2 市場予測
9.5 中南米
9.5.1 市場動向
9.5.2 市場予測
10 世界のエネルギーベース治療薬産業：SWOT分析
10.1 概要
10.2 強み
10.3 弱点
10.4 機会
10.5 脅威
11 世界のエネルギーベース治療薬産業：バリューチェーン分析
12 世界のエネルギーベース治療薬産業：バリューチェーン分析ポーターズファイブフォース分析
12.1 概要
12.2 買い手の交渉力
12.3 供給者の交渉力
12.4 競争の程度
12.5 新規参入の脅威
12.6 代替品の脅威
13 世界のエネルギーベース治療薬産業：価格分析
14 競争環境
14.1 市場構造
14.2 主要プレイヤー
14.3 主要プレーヤーのプロフィール
14.3.1 ジョンソン・エンド・ジョンソン
14.3.2 ルメニス
14.3.3 シネロンメディカル
14.3.4 アボットメディカルオプティクス
14.3.5 アルコン
14.3.6 アルナメディカルシステム
14.3.7 アンジオダイナミクス
14.3.8 アトリキュア
14.3.9 バイオラーゼ
図1：世界：エネルギーベース治療薬市場：主な促進要因と課題
図2：世界：エネルギーベースの治療薬市場：販売額（単位：億米ドル）、2019年～2024年
図3：世界：エネルギーベース治療薬市場：図3：エネルギーベース治療薬の世界市場：技術タイプ別内訳（単位：%）、2024年
図4：エネルギーベース治療薬の世界市場：技術タイプ別内訳（単位：%）、2024年図4：エネルギーベース治療薬の世界市場：臨床用途別構成比（%）、2024年
図5：エネルギーベース治療薬の世界市場：臨床用途別構成比（%）、2024年図5：エネルギーベース治療薬の世界市場：エンドユーザー別内訳（%）、2024年
図6：エネルギーベース治療薬の世界市場：エンドユーザー別構成比（単位：%）、2024年図6：エネルギーベース治療薬の世界市場：地域別構成比（%）、2024年
図7：エネルギーベース治療薬の世界市場予測：販売額（単位：億米ドル）、2025年-2033年
図8：世界：エネルギーベース治療薬産業：SWOT分析
図9：世界：エネルギーに基づく治療薬産業：バリューチェーン分析
図10: 世界：エネルギーベース治療薬産業：ポーターのファイブフォース分析
図11：世界：エネルギーベース治療薬（レーザーベース）市場：販売額（単位：百万米ドル）、2019年および2024年
図12：世界：エネルギーベース治療薬（レーザーベース）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図13：世界：エネルギーベースの治療薬（光ベース）市場：販売額（単位：百万米ドル）、2019年・2024年
図14：世界のエネルギーベース治療薬（光ベース）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図15：世界のエネルギーベース治療薬（高周波ベース）市場：販売額（単位：百万米ドル）、2019年・2024年
図16：世界のエネルギーベース治療薬（高周波ベース）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図17：世界のエネルギーベース治療薬（超音波ベース）市場：販売額（単位：百万米ドル）、2019年・2024年
図18：世界のエネルギーベース治療薬（超音波ベース）市場予測：販売額（単位：百万米ドル）、2025年-2033年
図19：世界のエネルギーベース治療薬（熱）市場：販売額（単位：百万米ドル）、2019年・2024年
図20：世界：エネルギーベースの治療薬（熱）市場予測：販売額（単位：百万米ドル）、2025年-2033年
図21：世界のエネルギーベース治療薬（その他）市場：販売額（単位：百万米ドル）、2019年・2024年
図22：エネルギーベースの治療薬（その他）の世界市場予測：販売額（単位：百万米ドル）、2025年-2033年
図23：世界のエネルギーベース治療薬（美容）市場：販売額（単位：百万米ドル）、2019年・2024年
図24：エネルギーベースの治療薬（美容）の世界市場予測：販売額（単位：百万米ドル）、2025年-2033年
図25：世界：エネルギーベース治療薬（外科）市場：販売額（単位：百万米ドル）、2019年および2024年
図26：世界：エネルギーベースの治療薬（外科用）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図27：世界：エネルギーベース治療薬（眼科）市場：販売額（単位：百万米ドル）、2019年および2024年
図28：世界：エネルギーベース治療薬（眼科）市場予測：販売額（単位：百万米ドル）、2025年-2033年
図29：世界：エネルギーベース治療薬（病院）市場：販売額（単位：百万米ドル）、2019年および2024年
図30：世界：エネルギーベースの治療薬（病院）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図31：世界：エネルギーベース治療（診療所）市場：販売額（単位：百万米ドル）、2019年および2024年
図32：世界：エネルギーベースの治療薬（診療所）市場予測：販売額（単位：百万米ドル）、2025年〜2033年
図33：世界：エネルギーベース治療薬（その他）市場：販売額（単位：百万米ドル）、2019年および2024年
図34：世界：エネルギーベースの治療薬（その他）市場予測：販売額（単位：百万米ドル）、2025年-2033年
図35：北米：エネルギーに基づく治療薬市場エネルギーベースの治療薬市場販売額（単位：百万米ドル）、2019年および2024年
図36：北米：エネルギーベースの治療薬市場予測エネルギーベースの治療薬市場予測：販売額（単位：百万米ドル）、2025年～2033年
図37：欧州：エネルギーに基づく治療薬市場エネルギーベースの治療薬市場：販売額（単位：百万米ドル）、2019年および2024年
図38：欧州：エネルギーベースの治療薬市場予測：2019年および2024年エネルギーベースの治療薬市場予測：販売額（単位：百万米ドル）、2025年～2033年
図39：アジア太平洋地域エネルギーベースの治療薬市場：販売額（単位：百万米ドル）、2019年および2024年
図40：アジア太平洋地域のエネルギーベースの治療薬市場予測：販売額（単位：百万米ドル）、2025年～2033年
図41：中東およびアフリカ：エネルギーベースの治療薬市場：販売額（単位：百万米ドル）、2019年および2024年
図42：中東およびアフリカ：エネルギーベースの治療薬市場予測：販売額（単位：百万米ドル）、2025年～2033年
図43：ラテンアメリカ：エネルギーベースの治療薬市場：販売額（単位：百万米ドル）、2019年および2024年
図44：ラテンアメリカ：エネルギーベースの治療薬市場予測：2019年および2024年エネルギーベースの治療薬市場予測：販売額（単位：百万米ドル）、2025年～2033年
[表一覧］
表1：世界：エネルギーベースの治療薬市場：主要産業ハイライト、2024年および2033年
表2：世界：エネルギーベースの治療薬市場予測：技術タイプ別内訳（単位：百万米ドル）、2025年〜2033年
表3：エネルギーベース治療薬の世界市場予測：臨床用途別内訳（単位：百万米ドル）、2025-2033年
表4：エネルギーベースの治療薬の世界市場予測：エンドユーザー別内訳（単位：百万米ドル）、2025-2033年
表5：エネルギーベースの治療薬の世界市場予測：地域別内訳（単位：百万米ドル）、2025-2033年
表6：世界のエネルギーベース治療薬市場構造
表7：世界のエネルギーベース治療薬市場：主要プレイヤー
The global energy-based therapeutics market size reached USD 8.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.18% during 2025-2033. The global market is primarily driven by continual advancements in technology, increasing demand for non-invasive treatments, rising chronic disease prevalence, expanding healthcare infrastructure, enhanced treatment precision, supportive regulatory frameworks, and a rise in strategic industry collaborations.
Energy-Based Therapeutics Market Analysis:
Market Growth and Size: The global market is experiencing robust growth, driven by an increasing demand for both aesthetic and medical applications. It is a substantial and expanding market, with laser-based technology emerging as the largest segment.
Major Market Drivers: Key drivers of market growth include rapid technological advancements, a growing preference for non-invasive procedures, the rising prevalence of chronic diseases, government and regulatory support, and an aging population seeking advanced medical treatments.
Technological Advancements: Rapid technological advancements have led to the development of more efficient and effective therapeutic devices. Innovations such as minimally invasive laser therapies, precise targeting through imaging technologies, and the integration of AI and IoT have enhanced treatment efficacy and patient outcomes.
Industry Applications: The therapeutics market encompasses a wide range of clinical applications, including aesthetic, surgical, and ophthalmic. Aesthetic applications are the largest segment, driven by consumer demand for non-invasive cosmetic procedures.
Key Market Trends: Market trends include the increasing demand for non-invasive and minimally invasive treatments, the adoption of energy-based therapies in oncology and cardiology, and the continued growth of the industry due to the aging global population.
Geographical Trends: Geographically, the market exhibits global growth, with regional variations in the adoption of energy-based therapies. North America and Europe are prominent markets, while Asia-Pacific is showing substantial growth potential.
Competitive Landscape: The market features a competitive landscape with numerous companies offering a variety of energy-based devices and technologies. Competition is driven by innovations, regulatory approvals, and the ability to meet changing healthcare demands.
Challenges and Opportunities: Challenges in the market include regulatory compliance, safety concerns, and the need for continuous innovation. However, opportunities abound due to the increasing demand for energy-based therapies, especially in emerging markets, and the potential for further technological advancements.
Energy-Based Therapeutics Market Trends:
Continual technological advancements
Emerging innovations in this sector have led to the development of more efficient and effective therapeutic devices, which utilize various forms of energy such as laser, ultrasound, radiofrequency, and electromagnetic therapy. These advancements enhance the efficacy of treatments and reduce side effects, making the procedures more acceptable to patients. The introduction of minimally invasive laser therapies has revolutionized dermatological and cosmetic procedures. Furthermore, advancements in imaging technologies have enabled precise targeting during energy-based treatments, improving outcomes in cancer therapy, pain management, and other medical conditions. The integration of AI and IoT in these devices has further personalized treatment options, optimizing energy delivery tailored to individual patient needs.
Growing demand for non-invasive procedures
An increase in consumer preference for non-invasive or minimally invasive procedures is a key factor propelling the global market. These procedures, which often use energy-based devices, are favored due to their numerous benefits such as reduced recovery time, lower risk of infection, minimal scarring, and shorter hospital stays. This trend is particularly evident in cosmetic and aesthetic treatments, where patients seek effective solutions with minimal downtime. The demand is also rising in other medical fields, including oncology, gynecology, and cardiology, where energy-based therapies offer a non-invasive alternative to traditional surgeries. This shift is further supported by the aging population, who are more susceptible to chronic diseases and often prefer less invasive treatment options.
Rising prevalence of chronic diseases
The escalation in chronic diseases such as cancer, cardiovascular disorders, and various neurological conditions is a significant factor fueling the growth of the market. These conditions often require precise and targeted treatment approaches, for which energy-based therapies are increasingly being recognized. In oncology, energy-based treatments, including radiofrequency ablation and laser therapy are being used for tumor destruction, offering an alternative to conventional surgical procedures. In cardiovascular care, technologies such as catheter-based ablation are effective in treating arrhythmias. Additionally, the growing burden of chronic pain and the need for effective management solutions have led to the adoption of energy-based pain relief therapies. As the global population ages, the incidence of these chronic conditions is expected to rise, subsequently increasing the demand for energy-based therapeutic interventions.
Energy-Based Therapeutics Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2025-2033. Our report has categorized the market based on technology type, clinical application, and end-user.
Breakup by Technology Type:
• Laser Based
• Light Based
• Radiofrequency Based
• Ultrasound Based
• Thermal
• Others
Laser based accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the technology type. This includes laser based, light based, radiofrequency based, ultrasound based, thermal, and others. According to the report, laser based represented the largest segment.
Laser-based energy therapy holds the dominant position in the market, due to its precision and versatility. This technology employs concentrated beams of light to target tissues, making it ideal for various medical applications, including dermatology, ophthalmology, and aesthetics. Laser-based therapies are widely adopted for skin resurfacing, tattoo removal, hair removal, and vision correction procedures. The high demand for these treatments, driven by cosmetic and medical needs, positions laser-based technology as the largest segment in the global therapeutics market.
Furthermore, light-based energy therapies, often referred to as intense pulsed light (IPL) or phototherapy, utilize visible and near-infrared light to target specific skin conditions. These therapies are particularly effective in addressing issues such as pigmentation irregularities, vascular lesions, and sun damage. They are widely employed in non-invasive cosmetic applications, contributing to the field of skin rejuvenation.
On the other hand, radiofrequency-based energy therapies rely on radio waves to generate controlled heat within the skin's tissues. This heat, in turn, stimulates collagen production, leading to skin tightening and wrinkle reduction. The non-invasive nature of radiofrequency technology makes it a valuable segment in the market, primarily within the field of aesthetic medicine.
Moreover, ultrasound-based energy therapies use focused ultrasound waves to target tissues deep within the body. This technology has gained prominence in the non-surgical body contouring and skin tightening market. It is particularly popular for addressing areas with stubborn fat deposits and loose skin. Patients appreciate ultrasound-based treatments for their non-invasive nature and minimal downtime compared to traditional surgical procedures.
Additionally, thermal-based energy therapies encompass a variety of techniques that involve controlled heating of tissues. These therapies are often utilized in pain management, particularly for addressing chronic pain conditions. They work by applying heat to specific areas to reduce pain and improve overall comfort. Thermal-based technology remains an essential part of the market, serving specific medical needs and improving the quality of life for patients with chronic pain.
Breakup by Clinical Application:
• Aesthetic
• Surgical
• Ophthalmic
Aesthetic holds the largest share in the industry
A detailed breakup and analysis of the market based on the clinical application have also been provided in the report. This includes aesthetic, surgical, and ophthalmic. According to the report, aesthetic accounted for the largest market share.
The aesthetic segment represents the largest portion of the market. Aesthetic applications encompass a wide range of treatments aimed at enhancing an individual's appearance and addressing cosmetic concerns. Energy-based therapies such as laser and light-based procedures are extensively used for skin rejuvenation, hair removal, tattoo removal, body contouring, and wrinkle reduction. The growing demand for non-invasive and minimally invasive cosmetic procedures, driven by consumer desire for youthful and attractive aesthetics, positions this segment at the forefront of the market.
Moreover, the surgical segment of the market focuses on medical procedures that require precise and controlled energy-based tools. These applications include the treatment of various medical conditions, such as the removal of tumors through techniques, including radiofrequency ablation or the correction of refractive vision errors with laser-based eye surgeries. Surgical applications represent a substantial portion of the market, as energy-based therapies offer safer and more efficient alternatives to traditional surgical methods, reducing patient downtime and complications.
Additionally, ophthalmic applications involve the use of energy-based therapies for eye-related conditions and vision correction procedures. Laser-based technologies, such as LASIK have revolutionized the field of ophthalmology by providing precise and effective treatments for refractive errors such as myopia, hyperopia, and astigmatism. Ophthalmic applications, while a smaller segment compared to aesthetics and surgery.
Breakup by End-User:
• Hospital
• Clinics
• Others
Clinics represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospital, clinics, and others. According to the report, clinics represented the largest segment.
The clinics segment represents the largest portion of the market. Clinics, including dermatology clinics, medical spas, and specialized aesthetic centers, serve as key hubs for energy-based treatments, particularly in the aesthetic and cosmetic fields. Patients seeking non-invasive cosmetic procedures often prefer the convenience and accessibility of clinics, where they can receive treatments such as laser skin resurfacing, hair removal, and body contouring. Additionally, clinics are equipped with state-of-the-art energy-based devices and trained medical professionals, making them the go-to choice for a wide range of aesthetic and medical treatments.
On the other hand, hospitals offer a variety of energy-based treatments, they are more likely to focus on surgical and medical applications that require a higher level of expertise and infrastructure. Energy-based surgeries, such as those used in oncology or ophthalmology, often take place in hospital settings due to the need for specialized equipment and the involvement of surgical teams.
Breakup by Region:
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
North America leads the market, accounting for the largest energy-based therapeutics market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.
North America stands as the largest segment in the market, primarily driven by the United States and Canada. The region boasts a well-established healthcare infrastructure, high healthcare expenditure, and a strong focus on technological advancements. These factors contribute to the widespread adoption of energy-based therapies in various clinical applications, including aesthetics, surgery, and ophthalmology. Additionally, a growing demand for non-invasive and minimally invasive procedures, coupled with a high awareness of cosmetic and medical treatments, propels the market's growth in North America.
Furthermore, the Asia Pacific region is a dynamic and rapidly growing segment in the energy-based therapeutics market. Countries, including China, Japan, South Korea, and India are witnessing substantial market expansion. The region's large population, increasing disposable income, and a burgeoning middle-class population with a strong interest in aesthetics contribute to the growing adoption of energy-based therapies.
Additionally, Europe represents another significant segment in the global market. Countries within the European Union, such as Germany, France, and the United Kingdom, are key contributors to the region's market share. Europe benefits from a well-regulated healthcare system and a mature aesthetic and medical services industry. The demand for energy-based treatments in aesthetic clinics and hospitals, along with the aging population seeking non-invasive procedures, sustains market expansion in this region.
On the contrary, Latin America is an emerging segment in the market, characterized by a growing awareness of cosmetic and medical treatments. Countries, such as Brazil and Mexico are prominent players in the region's market. The rising middle-class population and increasing healthcare investments are augmenting the adoption of energy-based therapies in this region, particularly in aesthetic applications.
Moreover, the Middle East and Africa form a developing segment within the market. Countries, such as the United Arab Emirates and South Africa are at the forefront of market growth in the region. The demand for aesthetic treatments and advanced medical procedures in these areas, driven by tourism, healthcare investments, and a desire for improved aesthetics, contributes to the expansion of the market in the Middle East and Africa.
Leading Key Players in the Energy-Based Therapeutics Industry:
Key players in the market are actively engaged in various strategic initiatives to maintain their competitive edge. These initiatives typically include research and development efforts to innovate and launch advanced energy-based devices with improved efficiency and safety profiles. They also focus on expanding their market presence through partnerships, collaborations, and acquisitions, allowing them to tap into new geographical markets and broaden their product portfolios. Additionally, key players prioritize regulatory compliance and work closely with regulatory agencies to gain approvals for their devices. Furthermore, they invest in marketing and educational campaigns to raise awareness about the benefits of energy-based therapies among healthcare professionals and patients, driving market adoption.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
• Johnson & Johnson
• Lumenis
• Syneron Medical
• Abbott Medical Optics
• Alcon
• Alna Medical System
• Angiodynamics
• Atricure
• Biolase
Key Questions Answered in This Report
1.What was the size of the global energy-based therapeutics market in 2024?
2.What is the expected growth rate of the global energy-based therapeutics market during 2025-2033?
3.What are the key factors driving the global energy-based therapeutics market?
4.What has been the impact of COVID-19 on the global energy-based therapeutics market?
5.What is the breakup of the global energy-based therapeutics market based on the technology type?
6.What is the breakup of the global energy-based therapeutics market based on the clinical application?
7.What is the breakup of the global energy-based therapeutics market based on the end-user?
8.What are the key regions in the global energy-based therapeutics market?
9.Who are the key players/companies in the global energy-based therapeutics market?
